Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide.
D000082:Acetaminophen / Q000008:administration & dosage / Q000494:pharmacology*; D000284:Administration, Oral; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D004952:Esters / Q000494:pharmacology; D005449:Fluorenes / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D006965:Hyperplasia; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009374:Neoplasms, Experimental; D051381:Rats; D013431:Sulfates / Q000008:administration & dosage / Q000494:pharmacology / Q000652:urine; D013997:Time Factors
D004952:Esters; D005449:Fluorenes; D006877:Hydroxamic Acids; D013431:Sulfates; D000082:Acetaminophen